S. Supiot

7.2k citations
231 papers · 3.1k indexed · h-index 31

S. Supiot

207 papers receiving 3.1k citations

Peers

S. Supiot
Comparison fields: 5 of 117
  • Radiation 840
  • Pulmonary and Respiratory Medicine 1.7k
  • Radiology, Nuclear Medicine and Imaging 880
  • Cancer Research 390
  • Oncology 632
Replace Mitchell Kamrava with:
Mitchell Kamrava United States
Alberto Bossi France
John Staffurth United Kingdom
John Logue United Kingdom
D.A. Loblaw Canada
Drew Moghanaki United States
Alan Herschtal Australia
Alexander V. Louie Canada
T.A. DeWees United States
Nils H. Nicolay Germany
S. Supiot relative to Mitchell Kamrava United States Mitchell Kamrava's profile →
Citations per field
00.5×1.5×1.8×
Mitchell Kamrava · 1×
Citations per year

Countries citing papers authored by S. Supiot

Since Specialization
Citations

This map shows the geographic impact of S. Supiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Supiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Supiot more than expected).

Fields of papers citing papers by S. Supiot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Supiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Supiot. The network helps show where S. Supiot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Supiot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Supiot Line = papers co-authored together S. Supiot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20250
4 20243
5 20247
6 20240
7 20241
8 20230
9 20230
10 20231
11 20233
12 20231
13 20232
14 20230
15 20231
16 20227
17 20203
18 202019
19 20191
20 200987

About S. Supiot

S. Supiot is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 231 papers that have together received 3.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (104 papers), Prostate Cancer Diagnosis and Treatment (96 papers), Advanced Radiotherapy Techniques (69 papers), Radiation Therapy and Dosimetry (19 papers), Radiopharmaceutical Chemistry and Applications (18 papers), Bladder and Urothelial Cancer Treatments (18 papers), Glioma Diagnosis and Treatment (14 papers) and Urologic and reproductive health conditions (14 papers). The work is most often cited by research in Radiation (840 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Radiology, Nuclear Medicine and Imaging (880 citations). S. Supiot has collaborated with scholars based in France, Canada and Switzerland. Frequent co-authors include François Paris, Robert G. Bristow, G. Delpon, Vincent Potiron, L. Campion, I. Latorzeff, Sophie Chiavassa, Paul Sargos, G. Créhange and Marc-André Mahé. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Radiotherapy and Oncology, Frontiers in Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026